We could not find any results for:
Make sure your spelling is correct or try broadening your search.
The current MEOBF market cap is 849.69M. The company's latest EPS is USD -0.0807 and P/E is -13.75.
Year End 30 June 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
Total Revenue | 16M | 33.07M | 26.19M | 17.02M | 19.85M |
Operating Income | -87.89M | -74.81M | -90.41M | -73.76M | -60.44M |
Net Income | -89.8M | -77.94M | -98.81M | -91.35M | -81.89M |
Year End 30 June 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
Total Assets | 652.12M | 733.6M | 744.72M | 662.14M | 669.42M |
Total Liabilities | 171.06M | 184.28M | 163.32M | 165.1M | 167.58M |
Total Equity | 481.05M | 549.33M | 581.4M | 497.04M | 501.84M |
Year End 30 June 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
Operating | -57.79M | -56.37M | -106.68M | -65.78M | -63.27M |
Investing | -1M | -3.27M | -1.65M | -232k | -194k |
Financing | 71.61M | 137.04M | 114.47M | -9.87M | 74.5M |
Market Cap | 849.69M |
Price to Earnings Ratio | -13.75 |
Price to Sales Ratio | 56.63 |
Price to Cash Ratio | 15.81 |
Price to Book Ratio | 2.25 |
Dividend Yield | - |
Shares Outstanding | 1.02B |
Average Volume (1 week) | 100 |
Average Volume (1 Month) | 231 |
52 Week Change | -7.02% |
52 Week High | 1.00 |
52 Week Low | 0.10 |
Spread (Intraday) | 0.08 (10.89%) |
Company Name | Mesoblast Ltd (PK) |
Address |
level 38 melbourne, victoria 3000 |
Website | https://www.mesoblast.com |
Industry | biological pds,ex diagnstics (2836) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions